Justin Arnall, PharmD, discusses the clinical significance of his research and case study on, “Loss of Pregnancy in a Patient with Chronic Myeloid Leukemia During Treatment with Nilotinib.”
Loss of Pregnancy in a Patient with Chronic Myeloid Leukemia During Treatment with Nilotinib
Related Items




JHOP - September 2017 Vol 7, No 3 published on August 29, 2017 in Original Research





Nicolas De Padova, PharmD, Robert Grabowski, PharmD, Joseph Ineck, PharmD, CPE, Robert Mancini, PharmD, BCOP
JHOP - Sept 2016 Vol 6, No 3 published on August 22, 2016 in Original Research
Last modified: July 12, 2016